5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: Synthesis, biological activity and QSAR study
Authors:
- K. SrikanthKSK. Srikanth
- Suchandra BanerjeeSBSuchandra Banerjee
- Bikash DebnathBDBikash Debnath
- Shovanlal GayenSGShovanlal Gayen
- Tarun JhaTJTarun Jha
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (6) , 1413-1423
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Thalidomide as an anti‐cancer agentJournal of Cellular and Molecular Medicine, 2002
- Glutamine and CancerThe Journal of Nutrition, 2001
- Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell linesJournal of Cellular Physiology, 1998
- Glutamine requirement of proliferating T lymphocytesNutrition, 1997
- The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animalNutrition, 1997
- Glutamine, cancer, and its therapyThe American Journal of Surgery, 1996
- Glutamine as a Regulator of DNA and Protein Biosynthesis in Human Solid Tumor Cell LinesAnnals of Surgery, 1996
- l-glutamine: a major substrate for tumor cells in vivo?Journal of Cancer Research and Clinical Oncology, 1987
- Enzyme targets of antiglutamine agents in cancer chemotherapyAdvances in Enzyme Regulation, 1985